Research reportRole of L-type Ca2+ channels in pertussis toxin induced antagonism of U50,488H analgesia and hypothermia
Introduction
Opioid receptors belong to the family of G-protein coupled receptors and mediate the inhibition of adenylate cyclase, opening of voltage gated calcium (Ca2+) channels and promote the opening of potassium (K+) channels [6] by coupling mainly to Gi/o proteins [23]. These proteins (Gi/Go) are heterotrimeric in nature with α, β and γ subunit composition and shown to be sensitive to pertussis toxin (PTX) produced by Bordetella pertussis[6], [20], [39]. At the molecular level, PTX has been shown to ADP-ribosylate the α-subunit of guanine nucleotide regulatory proteins (Gi/Go) and hence interfere selectively with opioid receptor mediated inhibitory signal transduction [20], [39]. The PTX-sensitive Gi and Go proteins are known to mediate the inhibitory effects of opioids such as analgesia, hypothermia, etc. [6]. The κ-opioid receptor agonists are potent analgesics with minimal respiratory depression and physical dependence [27]. However, in addition to analgesia, κ-opioid agonists also produce hypothermia [3], [5], [14], [16], [30], [36].
Several studies have used PTX pretreatment as a tool to assess the role of G-protein mediated events on the pharmacodynamics of morphine. The pretreatment of PTX has been shown to reduce the analgesic effect of μ-opioid agonists [18], [26], [33], [34], [37], [40], [41], [46]. Moreover, PTX pretreatment converts the hypothermia produced by a high dose of morphine into consistent hyperthermia [2].
However, only few in vivo studies have assessed the effect of PTX pretreatment on the pharmacodynamics of κ-opioid agonists. In mice, PTX pretreatment blocked the U5H tail-flick analgesia [12]. The PTX pretreatment has been shown to antagonize the hypothermia and behavioral effects of κ-opioid agonists [4], [42]. In addition, PTX has been shown to regulate the Ca2+ channel currents through G-proteins (mainly Go) in neuroblastoma×glioma hybrid cells [17] and rat spinal cord–dorsal root ganglion co-cultures [1] providing a clear evidence for the role of PTX-sensitive G-protein coupling to Ca2+ channels. These authors reported that opiates inhibit the voltage-dependent Ca2+ channel currents in a PTX-sensitive manner. Moreover, there is ample evidence for direct coupling of κ-opioid receptors to L-type Ca2+ channels [1], [10], [11]. In addition, upregulation of L-type Ca2+ channels has been shown as a possible mechanism of hyperalgesia to morphine in mice following PTX pretreatment [32]. Furthermore, CCBs have been shown to potentiate κ-opioid agonist-induced analgesia [8], [28], [38] and hypothermic responses [14], [36]. In a recent study, we showed CCBs to potentiate κ-opioid agonist-induced analgesia and inhibit tolerance [15]. Despite the biochemical evidence for a direct coupling of κ-opioid receptors to voltage-sensitive Ca2+ channels via PTX-sensitive G-proteins [1], there are no in vivo studies assessing the role of Ca2+ channels in the effect of PTX pretreatment on the pharmacodynamics of κ-opioid agonists. So, the aim of the present study is to determine the (1) effect of PTX pretreatment on κ-opioid agonist, U5H-induced analgesic and hypothermic effects, (2) effect of NIM on PTX modulation of U5H-induced analgesia and hypothermia and (3) status of L-type Ca2+ channels in both saline and pertussis toxin (i.c.v.) pretreated rat brain membranes using [3H]PN200–110, a highly selective DHP radioligand.
Section snippets
Animals
Experiments were performed on male Sprague–Dawley rats weighing 175–200 g (Central Animal Facility, NIPER, India) housed four per cage in a room with controlled ambient temperature (23±1 °C), humidity (50±10%) and 12 h light–dark cycle. Food (pellet) and water were made freely available to rats except during experiment. Animals were used only once and received a single dose of the opioid drug. All experiments were performed between 09.00 and 17.00 h to minimize diurnal variation. The
Effect of NIM on PTX modulation of U5H induced analgesia in rats
In saline (i.c.v) treated rats, U5H (40 mg/kg, i.p.) produced significant (P<0.01) tail-flick analgesic response (AUC0–180min: 7755.4±995.6) with a peak % MPE of 67.2±11.7 (n=4) (Fig. 1). The PTX (1 μg/rat, i.c.v.) pretreatment (72 h before) significantly (P<0.01) blocked the U5H-induced analgesic response (% MPE: 31.1±8.7; AUC0–180min: 3266.9±847.9) (n=4) (Fig. 1). However, this blockade is only partial. Acute administration of NIM (1 mg/kg, i.p.) 15 min before U5H reversed the blockade of
Discussion
The effect of co-administration of NIM on PTX-induced changes in U5H analgesia, hypothermia, and the possible changes in DHP binding due to PTX were determined in the present study. The dose of either PTX (1 μg/rat, i.c.v.) or NIM (1 mg/kg, i.p.) used in the study did not modify the basal tail-flick latency and body temperature.
In the present study, U5H (40 mg/kg, i.p.) produced significant tail-flick analgesic response in saline-treated rats. These results are consistent with previous reports
Acknowledgements
S. Gullapalli acknowledges the Council of Scientific and Industrial Research (CSIR, New Delhi, India) for awarding a Senior Research Fellowship (9/727(5)/97-EMR-I). The authors are grateful to receive generous gift sample of U50,448H from M/s Pharmacia-Upjohn, Kalamazoo, Michigan, USA, and nimodipine from USV, Mumbai, India, and thank NIPER for providing facilities.
References (47)
- et al.
κ-Opiate agonists inhibit Ca2+ influx in rat spinal cord–dorsal root ganglion co-cultures: Involvement of a GTP-binding protein
J. Biol. Chem.
(1989) - et al.
Influence of pertussis toxin on thermic responses to morphine and neurotensin in rats
Eur. J. Pharmacol.
(1992) - et al.
Gi proteins and calcium in dynorphin-induced hypothermia and behavior
Eur. J. Pharmacol.
(1990) Opioid receptor-coupled second messengers
Life Sci.
(1991)- et al.
κ-Opioid receptor stimulation of [35S]GTPγS binding in guinea pig brain: lack of evidence of κ2 selective activation of G-proteins
Biochem. Pharmacol.
(1998) - et al.
Calcium channel antagonists and adenosine analogues decrease tolerance to opiate pentazocine and U50488H
Gen. Pharmacol.
(1993) - et al.
A novel κ agonist inhibits [3H]nimodipine binding to a Ca2+ channel receptor protein in rat brain
Biochem. Biophys. Res. Commun.
(1987) - et al.
The effect of κ agonist U50,488H on [3H]nimodipine receptor binding in rat brain regions
Eur. J. Pharmacol.
(1988) - et al.
Calcitonin reverts pertussis toxin blockade of the opioid analgesia in mice
Neurosci. Lett.
(1999) - et al.
Role of Ca2+ channels on the hypothermic response produced by activation of κ-opioid receptors
Pharmacol. Biochem. Behav.
(2002)
Effect of μ-, δ-, and κ-selective opioid agonists on thermoregulation in the rat
Pharmacol. Biochem. Behav.
Pertussis toxin inhibits antinociception produced by intrathecal injection of morphine, noradrenaline and baclofen
Eur. J. Pharmacol.
Modulation by islet-activating protein of adenylate cyclase activity in C6 glioma cells
J. Biol. Chem.
Gz Coupling to the rat κ-opioid receptor
FEBS Lett.
Protein measurement with Folin phenol reagent
J. Biol. Chem.
Modification of morphine-induced analgesia and toxicity by pertussis toxin
Brain Res.
κ-Opioid receptors and analgesia
Trends Pharmacol. Sci.
Interaction between analgesics and calcium channel blockers
Gen. Pharmacol.
Potentiation of κ opioid receptor agonist induced analgesia and hypothermia by fluoxetine
Pharmacol. Biochem. Behav.
Autoradiography of [3H]U-69,593 binding sites in rats brain: evidence for κ-opioid receptor subtypes
Eur. J. Pharmacol.
Pertussis toxin inhibits the antinociceptive action of morphine in the rat
Eur. J. Pharmacol.
Pertussis toxin inhibits morphine analgesia and prevent opiate dependence
Pharmacol. Biochem. Behav.
Interaction of κ receptor agonists with calcium channel antagonists in the modulation of hypothermia
Eur. J. Pharmacol.
Cited by (11)
An updated assessment of the translational promise of G-protein-biased kappa opioid receptor agonists to treat pain and other indications without debilitating adverse effects
2022, Pharmacological ResearchCitation Excerpt :This idea was driven by early studies in the Chavkin lab, which produced multiple papers suggesting that κOR agonist-induced dysphoria and aversion is dependent on β-arrestin-mediated p38 activation [7,15–17]. Thus, together with earlier in vivo studies that utilized the Gαi-protein inhibitor pertussis toxin to demonstrate that the analgesic effects of κOR agonists depended on G protein signaling [18–20], biasing κOR agonists towards G protein activation and away from β-arrestin signaling was predicted to be beneficial [5]. Later, the finding that κOR agonists remain antinociceptive in mice lacking β-arrestin 2 further confirmed that G protein signaling was necessary, whereas β-arrestin signaling was dispensable for therapeutic efficacy [21].
Development of functionally selective, small molecule agonists at kappa opioid receptors
2013, Journal of Biological ChemistryCitation Excerpt :There is considerable evidence that selective KOR agonists produce antinociception in animal models (9–12), and mice lacking KOR expression are no longer responsive to the antinociceptive effects of a selective KOR agonist U50,488 (13). The G protein-mediated signaling events are believed to contribute to the analgesic properties of KOR agonists (14, 15). Unlike MOR agonists, KOR agonists do not cause physical dependence nor do they produce respiratory failure; thus, they are attractive as potent analgesics (16).
Opioid-induced preconditioning: Recent advances and future perspectives
2005, Vascular PharmacologyThe diverse roles of arrestin scaffolds in g protein–coupled receptor signaling
2017, Pharmacological ReviewsEffects of endogenous cardioprotective mechanisms on ischemia-reperfusion injury
2017, Postepy Higieny i Medycyny Doswiadczalnej